Sanofi Pre-Tax Income 2010-2024 | SNY

Sanofi pre-tax income for the twelve months ending June 30, 2024 was $6.124B, a 46.82% decline year-over-year.

  • Sanofi annual pre-tax income for 2023 was $7.742B, a 29.5% decline from 2022.
  • Sanofi annual pre-tax income for 2022 was $10.981B, a 19.02% increase from 2021.
  • Sanofi annual pre-tax income for 2021 was $9.226B, a 41.49% decline from 2020.

Sanofi Pre-Tax Income 2010-2024 | SNY

  • Sanofi annual pre-tax income for 2023 was $7.742B, a 29.5% decline from 2022.
  • Sanofi annual pre-tax income for 2022 was $10.981B, a 19.02% increase from 2021.
  • Sanofi annual pre-tax income for 2021 was $9.226B, a 41.49% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Innoviva (INVA)$1.2B